옵션 체인은 다양한 행사가격과 만기일에 대한 Virax Biolabs Group의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Virax Biolabs Group에 대한 시장 심리를 평가합니다..

Virax Biolabs Group (NASDAQ:VRAX) 주식, 옵션 체인

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Broad U.S. Equity ETFs

Exclusives

Tech

Trading Ideas

ETFs

AAPL

AMZN

APDN

ASTS

CING

CRWD

GOVX

INDO

LUMN

LUNR

NVDA

PLTR

SERV

SMCI

TSLA

VRAX

ZAPP

매일의 거래일에는 트레이더들이 전체 시장과 개별 종목들에 대한 최신 뉴스를 볼 수 있는 소스인 Benzinga Pro에 수백 개의 헤드라인과 보도 자료가 제공된다. 2024년 8월 한 달 동안 Benzinga Pro에서 가장 많이 검색된 주식을 살펴보자. 현재 가격과 연간 실적은 8월 30일을 기준으로 하며 배당금은 포함되지 않았다. 4월 검색결과는 추적되지 않았다.

단독: 2024년 8월 벤징가 프로에서 가장 검색량이 많았던 상위 20개 티커는?

Virax Biolabs Group Limited - Ordinary Shares

Virax Biolabs Group Ltd

<a href="https://www.reuters.com/business/energy/china-state-firms-curb-russian-oil-imports-sanctions-risks-sources-say-2025-03-14/" title="https://www.reuters.com/business/energy/china-state-firms-curb-russian-oil-imports-sanctions-risks-sources-say-2025-03-14/">https://www.reuters.com/business/energy/china-state-firms-curb-russian-oil-imports-sanctions-risks-sources-say-2025-03-14/</a>

News

Commodities

Markets

Reuters Reported Earlier, China State Firms Curb Russian Oil Imports On Sanctions Risks

RLX Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLX#NYSE">RLX</a>) reported quarterly earnings of $0.03 per share. This is a 43.48 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $111.45 million in sales this quarter. This is a 52.03 percent increase over sales of $73.31 million the same period last year.

Earnings

RLX Technology Q4 Adj $0.03 Down From $0.05 YoY, Sales $111.45M Up From $73.31M YoY

Macro Economic Events

Econ #s

Economics

China New Loans For February 1,010.0B Vs. 2,150.0B Est.; 5,130.0B Prior

B of A Securities analyst Michael McGovern maintains Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) with a Buy and lowers the price target from $270 to $220.

Price Target

Analyst Ratings

CVNA

B of A Securities Maintains Buy on Carvana, Lowers Price Target to $220

As a part of the strategy, the company's board of directors has approved the declaration of a special cash dividend of $6.30 per share. The total amount of the special dividend payment will be approximately $1.5 billion, based on the current number of shares outstanding. The special cash dividend is payable on April 17, 2025, to stockholders of record on April 3, 2025.

Dividends

Pilgrim's Pride Announces $6.30/Share Special Dividend Payable April 17, Plans Investments In Brand Growth, Prepared Foods, And Retail Expansion

WIIM

RDUS

Radius Recycling shares are trading higher after the company disclosed a merger deal with Toyota Tsusho America, Inc. for $30.00 per share in cash

Baird analyst David George upgrades American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) from Underperform to Neutral and maintains the price target from $265 to $265.

Upgrades

Baird Upgrades American Express to Neutral, Maintains Price Target to $265

Radius Recycling, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDUS#NASDAQ">RDUS</a>) shares are shooting higher premarket on Friday. On Thursday, the company disclosed a definitive merger agreement with Toyota Tsusho America, Inc. <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44317642/radius-recycling-to-be-acquired-by-u-s-subsidiary-of-toyota-tsusho-corporation-ttc-accelerating-in" rel="noreferrer noopener">for $30.00 per share in cash</a>.
The acquisition price offers around a 115% premium over Radius&#8217; closing share price, and around a 102% premium over the 90-day volume-weighted average share price (VWAP) on March 12, 2025.
The total implied enterprise value of the transaction, including net debt, is approximately $1.34 billion.
The transaction is expected to close in the second half of 2025, pending approval by Radius&#8217; shareholders and other customary closing conditions.
Toyota Tsusho, which is the U.S. subsidiary of Toyota Tsusho Corporation&nbsp;(TTC) expects Radius to become a consolidated subsidiary during <a target="_blank" href="https://www.toyota-tsusho.com/english/press/upload_files/4cb197adb99df7a36ed659cd47a65b11.pdf" rel="noreferrer noopener">the </a>next fiscal year (fiscal year ending March 31, 2026).
Radius anticipates leveraging TTC&#8217;s strong connections with automotive OEMs and suppliers at all tiers, which will open up more opportunities to collaborate with metals consumers.
This expanded customer base will strengthen Radius&#8217; operational platform, enabling it to invest in facilities, drive growth, and offer enhanced products and services.
Tamara L. Lundgren, Radius&#8217; Chairman and Chief Executive Officer, said, &#8220;We are excited to have reached this agreement with TTC, which builds on our longstanding relationship and provides us with increased opportunities for our talented team, broader products and services for our suppliers, customers and communities, and an expanded platform for our more than 100 operating sites while delivering significant immediate value to our shareholders,&#8221;&nbsp;
As of December 31, 2024, TTC&#8217;s cash and cash equivalent stood <a target="_blank" href="https://www.toyota-tsusho.com/english/ir/earnings-presentations/upload_files/E_tanshin_104_3Q.pdf" rel="noreferrer noopener">at </a>JPY860 billion (around $5.78 billion).
In January, Radius reported first-quarter&nbsp;revenue of&nbsp;$656.54 million, missing&nbsp;the consensus of&nbsp;$665.6 million, and adjusted loss per share of $1.33,&nbsp;<a target="_blank" href="https://www.benzinga.com/25/01/42876979/radius-recyclings-q1-fy25-revenue-falls-short-declines-in-ferrous-sales-weigh-on-results" rel="noreferrer noopener">missing the consensus loss of $0.10</a>.
Price Action: RDUS shares are up 109.0% at $28.55 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44312560/goldman-sachs-sees-favorable-supply-demand-outlook-for-mosaic-bullish-on-fmc-and-corteva" target="_blank" rel="noreferrer noopener">Goldman Sachs Agri Stock Picks: Corteva&#8217;s R&amp;D Edge, FMC&#8217;s Pipeline, And Mosaic&#8217;s Phosphate Advantage Set Up Strong Growth</a></li>
</ul>
Photo via Shutterstock

Equities

Small Cap

Movers

Radius Recycling Lands Merger Deal At 115% Premium, Stock Skyrockets

DOYU

DouYu Intl Hldgs Q4 Adj EPADS $(0.31), Sales $155.63M Down From $182.53M YoY

WeRide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) reported quarterly losses of $(3.51) per share. The company reported quarterly sales of $49.50 million which beat the analyst consensus estimate of $48.53 million by 2.00 percent.

Earnings Beats

WeRide FY 2024 GAAP EPADS $(3.51), Sales $49.50M Beat $48.53M Estimate

Piper Sandler analyst Brent Bracelin maintains ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) with a Overweight and maintains $125 price target.

TTAN

Piper Sandler Maintains Overweight on ServiceTitan, Maintains $125 Price Target

Shares of Rubrik, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter<a href="https://in.benzinga.com/news/earnings/25/03/44317342/rubrik-stock-climbs-after-strong-q4-results-q1-guidance-above-estimates"> guidance above estimates</a>.
Rubrik reported quarterly losses of 61 cents per share, which beat the analyst consensus estimate for losses of 80 cents. Quarterly revenue clocked in at $258.1 million, which beat the analyst consensus estimate of $233.1 million.
Rubrik shares climbed 20.8% to $66.84 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Radius Recycling, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDUS#NASDAQ">RDUS</a>) rose 108.7% to $28.51 in pre-market trading after the company agreed to be acquired by US subsidiary of Toyota Tsusho for $30.00 per share in cash.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) gained 56.5% to $24.83 in pre-market trading after the company announced a warrant issuance agreement transaction with Amazon for 7,945,399 shares.</li>
<li>MEDIROM Healthcare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) gained 48.6% to $0.91 in pre-market trading. MEDIROM Mother Labs executive made an additional investment in Mother Labs&#8217; Series A financing at a pre-money valuation of JPY9 billion.</li>
<li>Cellectis S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLLS#NASDAQ">CLLS</a>) gained 40.3% to $1.81 in pre-market trading after the company announced upbeat financial results for the fourth quarter.</li>
<li>Bit Origin Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) gained 37.2% to $0.3743 in pre-market trading after declining 26% on Thursday.</li>
<li>Digital Ally, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) gained 23.2% to $0.0978 in pre-market trading. Digital Ally has been granted six new patents covering diverse sectors.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) rose 19% to 0.8827. TransCode Therapeutics, on Thursday, announced Safety Review Committee approval to open a fourth cohort of its Phase I/II Clinical trial of TTX-MC138.</li>
<li>DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) gained 12.2% to $83.75 in pre-market following better-than-expected fourth-quarter financial results.</li>
<li>Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) rose 7% to $336.26 in pre-market trading as the company reported stronger-than-expected fourth-quarter financial results. Ulta Beauty expects fiscal year 2025 revenue of $11.5 billion to $11.6 billion versus estimates of $11.67 billion, according to Benzinga Pro. The company anticipates full-year earnings of $22.50 to $22.90 per share versus estimates of $23.50 per share.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Xponential Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPOF#NYSE">XPOF</a>) shares fell 30.8% to $8.39 in pre-market trading after the company announced fourth-quarter results.</li>
<li>Linkage Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCB#NASDAQ">LGCB</a>) declined 21.8% to $0.1797 in pre-market trading.</li>
<li>Septerna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) dipped 21.4% to $5.02 in pre-market trading after falling 5% on Thursday.</li>
<li>Olema Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) fell 15.1% to $3.71 in pre-market trading.</li>
<li>Icon Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) shares fell 14.7% to $0.1160 in pre-market trading. ICON Energy received non-compliance letter from the Nasdaq.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) fell 13.4% to $12.20 in pre-market trading. Relevant Gold closed second tranche of upsized $8.5 million non-brokered private placement led by strategic investors Kinross and Bollinger.</li>
<li>ImmunoPrecise Antibodies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) fell 11.8% to $0.3572 in today's pre-market trading. ImmunoPrecise Antibodies shares gained over 11% on Thursday after the company announced a strategic partnership to advance antibody-drug conjugates and bispecific antibodies for cancer.</li>
<li>SenesTech, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNES#NASDAQ">SNES</a>) shares tumbled 10% to $2.16 in pre-market trading after gaining 5% on Thursday. SenesTech recently reported better-than-expected quarterly EPS results.</li>
<li>SI-BONE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) fell 8.2% to $13.51 in pre-market trading. SI-BONE recently reported better-than-expected fourth-quarter EPS results and issued FY25 sales guidance above estimates.</li>
<li>XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares dipped 5.4% to $23.99 in pre-market trading. XPeng recenty announced to spend up to $13.8 billion on humanoid robots.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/markets/25/03/44300558/jim-cramer-arthur-j-gallagher-is-solid-this-industrial-company-is-fantastic">Jim Cramer: Arthur J. Gallagher Is &#8216;Solid,&#8217; This Industrial Company Is &#8216;Fantastic&#8217;</a></li>
</ul>

Pre-Market Outlook

AAOI

BTOG

CLLS

DGLY

DOCU

ICON

LGCB

OLMA

RBRK

RNAZ

SEPN

SIBN

SNES

ULTA

XPEV

XPOF

Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Piper Sandler analyst Arvind Ramnani maintains Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) with a Overweight and lowers the price target from $429 to $396.

Piper Sandler Maintains Overweight on Accenture, Lowers Price Target to $396

France Harmonised Index of Consumer Prices (MoM) For February 0.1% Vs. 0.0% Est.; -0.2% Prior

France Consumer Price Index (MoM) For February 0.0% Vs. 0.2% Est.; 0.1% Prior

Business Outlook
For the first quarter of 2025, the Company expects:
<ul>
<li>Deliveries of vehicles&nbsp;to be between 88,000 and 93,000 vehicles, representing a year-over-year increase of 9.5% to 15.7%. &nbsp;</li>
<li>Total revenues to be between RMB23.4 billion (US$3.2 billion) and RMB24.7 billion (US$3.4 billion), representing a year-over-year decrease of 8.7% to 3.5%.</li>
</ul>

Guidance

Li Auto Expects Q1 Vehicle Deliveries Of 88K-93K, Up By 9.5%-15.7% YoY

Business Outlook
For the first quarter of 2025, the Company expects:
<ul>
<li>Deliveries of vehicles&nbsp;to be between 88,000 and 93,000 vehicles, representing a year-over-year increase of 9.5% to 15.7%. &nbsp;</li>
<li>Total revenues to be between RMB23.4 billion (US$3.2 billion) and RMB24.7 billion (US$3.4 billion), representing a year-over-year decrease of 8.7% to 3.5%. &nbsp;</li>
</ul>

Li Auto Expects Q1 Revenue Of RMB23.4B ($3.2B)-RMB24.7B ($3.4B) Vs RMB31.77B Est

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &#8220;Extreme Fear&#8221; zone on Thursday.
U.S. stocks settled lower on Thursday, with the Dow Jones index falling more than 500 points during the session following the release of economic data.
U.S. producer prices came in unchanged in February from January compared to a revised 0.6% increase in the previous period and versus estimates of a 0.3% gain. U.S. initial jobless claims declined by 2,000 to 220,000 in the first week of March, compared to market estimates of 225,000.
On Thursday, U.S. President Donald Trump threatened to impose a 200% tariff on European wine and spirits imports unless the EU eliminates its 50% tariff on U.S. whiskey.
Shares of Dollar General Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) gained around 7% on Thursday after the company reported better-than-expected fourth-quarter sales results. UiPath Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) shares dipped around 16% after the company reported a fourth-quarter revenue miss and issued first-quarter revenue guidance below estimates.
Most sectors on the S&amp;P 500 closed on a negative note, with consumer discretionary, real estate and communication services stocks recording biggest losses on Thursday. However, utilities stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 537 points to 40,813.57 on Thursday. The S&amp;P 500 fell 1.39% to 5,521.52, while the Nasdaq Composite dipped 1.96% at 17,303.01 during Thursday's session.
Investors are awaiting earnings results from Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), RLX Technology Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLX#NYSE">RLX</a>) and The Buckle, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKE#NYSE">BKE</a>) today.
At a current reading of 14.8, the index remained in the &#8220;Extreme Fear&#8221; zone on Thursday, versus a prior reading of 20.7.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44298504/top-3-health-care-stocks-youll-regret-missing-this-quarter">Top 3 Health Care Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>

PATH

Dow Tumbles Over 500 Points On Tariff Threats; Fear Continues To Grip Markets, Fear & Greed Index Remains In 'Extreme Fear' Zone

With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) to report quarterly earnings at 34 cents per share on revenue of $6.76 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Li Auto shares gained 0.7% to $28.92 in after-hours trading.</li>
<li>Analysts are expecting RLX Technology Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLX#NYSE">RLX</a>) to post quarterly earnings at 20 cents per share on revenue of $794 million. The company will release earnings before the markets open. RLX Technology shares rose 1.3% to $2.38 in after-hours trading</li>
<li>DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) posted better-than-expected fourth-quarter financial results. The company said it sees fourth-quarter adjusted earnings of 86 cents per share on sales of $776.3 million. DocuSign shares jumped 11.9% to $83.59 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) reported stronger-than-expected fourth-quarter financial results. Ulta Beauty expects fiscal year 2025 revenue of $11.5 billion to $11.6 billion versus estimates of $11.67 billion, according to Benzinga Pro. The company anticipates full-year earnings of $22.50 to $22.90 per share versus estimates of $23.50 per share. Ulta Beauty shares gained 6.5% to $335.00 in the after-hours trading session.</li>
<li>Analysts expect The Buckle, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKE#NYSE">BKE</a>) to post quarterly earnings at $1.39 per share on revenue of $373.69 million before the opening bell. Buckle shares rose 1.3% to $35.60 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44298504/top-3-health-care-stocks-youll-regret-missing-this-quarter">Top 3 Health Care Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>

Ulta Beauty, DocuSign And 3 Stocks To Watch Heading Into Friday

Total deliveries for the fourth quarter of 2024 were 158,696 vehicles, representing a 20.4% year-over-year increase. &nbsp;

Li Auto's Q4 Total Deliveries Were 158.696K, Up By 20.4% YoY

Contracts

Press Releases

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Comments

Virax Biolabs Group

Virax Biolabs Group (VRAX) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌